A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents.

King, S; Griffin, S; Hodges, Z; Weatherly, H; Asseburg, C; Richardson, G; Golder, S; Taylor, E; Drummond, M; Riemsma, R; (2006) A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents. Health technology assessment (Winchester, England), 10 (23). iii-146. ISSN 1366-5278 DOI: https://doi.org/10.3310/hta10230

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.3310/hta10230

Abstract

Share

Download

Filename: FullReport-hta10230.pdf

Licence: Creative Commons: Attribution-Noncommercial-No Derivative Works 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar